Coffee Conversation with Steven Plymale and Milos Popovic at Toronto Rehabweek 2019
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
Release Date: 06/28/2019
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, host Dr. Ladan Jiracek sits down with Dr. , , whose lab uses intracranial brain recordings to study the biology of human cognition. Ignacio shares how cutting-edge neurotechnology like iEEG can reveal the neural dynamics behind decision-making, risk, memory, and brain states - and how those insights could unlock more targeted neuromodulation therapies for psychiatric disorders such as depression and anxiety. Top 3 Takeaways: Epilepsy patients undergoing seizure monitoring often have 100-200 electrodes implanted in their brains and may...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this solo episode of the Neural Implant Podcast, host Dr. Ladan Jiracek shares the story behind finally completing his PhD at the University of Florida - from the highs of passing his dissertation defense to the long, frustrating, and deeply technical journey of developing liquid crystal polymer (LCP)-based neural implants. I break down why LCP is so promising for long-term implantable devices, how delamination and bonding challenges became the core focus of his dissertation, and what it took to fabricate ultra-thin polymer electrodes approaching “biological invisibility.” I also...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, Paul Goode (Glucotrack) dives into the next wave of continuous glucose monitoring: an active, fully implantable CGM designed to deliver long-term, pacemaker-style reliability without external wearables. We discuss first-in-human progress, why implantables may change diabetes care at home, and a fascinating neural angle—how similar chemistry and form factors could be adapted to epidural glucose sensing and even paired with neural recording electrodes to capture metabolic and neural data together. If you care about closed-loop systems, chronic implants, or bridging...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, I speak with , Co-Founder and CSO of , an Italian neurotech company that is redefining the landscape of brain-computer interfaces. Corticale is pioneering a new generation of minimally invasive, CMOS-based neural implants that can record from thousands of neurons simultaneously—introducing their flagship technology, SiNAPS. Fabio walks us through how SiNAPS achieves single-cell resolution recordings via its 1024-electrode array, enabling high-fidelity access to both action potentials and local field potentials deep within cortical tissue. We...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, we sit down with , co-founder of , a groundbreaking medical technology company pioneering a new frontier in cancer treatment. By integrating neurotechnology, neurobiology, and machine learning, Coherence is building a platform that doesn't just fight cancer—it manages it in real time. Ben shares how Coherence is moving beyond the traditional "cut, burn, poison" model of oncology, and instead focusing on precision neuromodulation to monitor and control cancer progression—offering hope for 24/7 adaptive treatment with fewer side effects and...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we dive into the world of European intellectual property and medtech innovation with , a German and European Patent Attorney specializing in medical technology at . With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight. We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special episode recorded after the workshop in Barcelona, I talk with and , two of the key organizers behind the . We dive into the vision behind this growing event, which brings together top researchers, engineers, clinicians, and entrepreneurs to explore the cutting edge of implantable medical devices. Nicolas and Antoni share insights on the evolution of AIMD technologies, the role of multidisciplinary collaboration, and how this annual workshop is shaping the next generation of innovators. We also touch on the challenges that startups face in the space—regulatory hurdles, IP...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we sit down with , Chief Business Officer of , to explore a groundbreaking approach to treating obstructive sleep apnea. Lunosa is developing a self-expanding, injectable neurostimulator that aims to replace invasive facial surgeries with a minimally invasive, high-impact solution — tapping into a $10 billion market. Chad also reflects on his time at , a pioneering neuromodulation company that saw both innovation and controversy. He shares insights from testifying against Stimwave’s former CEO, lessons learned from the company’s collapse, and how those experiences shape...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special on-location episode recorded in Leuven, Belgium, we sit down with the co-founders and technical leaders of — (CEO), (CTO), and (CSO). The team shares their journey developing a high-density, intracortical visual prosthesis aimed at restoring vision for the blind. From developing reliable insertion technology to achieving long-term biocompatibility in nonhuman primate models, ReVision Implant is at the forefront of neurotech innovation. Tune in to hear about their challenges, breakthroughs, and what’s next in the race to cure blindness through brain stimulation. This...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we speak with , CEO and co-founder of , a contract research organization helping Medtech and Biopharma startups slash months off their clinical timelines. With a focus on Latin America, Bioaccess enables early feasibility and first-in-human trials to be conducted faster, more affordably, and with high-quality data suitable for FDA and EU submissions. Julio shares how their global site network—built over 20 years—helps startups navigate regulatory hurdles, reduce costs, and de-risk innovation, all while improving patient lives in emerging markets. This episode is sponsored...
info_outlineSteven Plymale is the CEO of MyndTec. He joined the firm in late 2017 and has more than 25 years of experience in the medical device industry. Previously, he was CEO of Profound Medical, bringing the company from a small six-person team to going public in 2015 in an IPO that raised $60 million. Plymale was also with Xltek, now a division of Natus Medical, and Claron Technologies.
Milos Popovic is the Director of the Toronto Rehabilitation Institute (KITE) and professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He is also the co-founder and director of the MyndTec. Popovic’s decade of research and randomized clinical trials with stroke and spinal cord injury populations led to the development of the MyndMove device.
Takeaways:
Multidisciplinary teams help to build a successful rehabilitation institute.
Translation of rehabilitation technology is not easy but it can be fun.
It is important to harness neuroplasticity in the body and the brain to achieve successful long-lasting outcomes in rehabilitation.
[0:00] Steven Plymale and Milos Popovic introduced themselves to kick off the conversation with Jen French from Neurotech Reports and Ladan.
[0:35] Milos Popovic describes how RehabWeek 2019 ended up being hosted in Toronto, the first time the event was held in North America, and the plan his team put together
[1:32] Popovic describes his career journey from a nuclear engineer to director of an innovative rehabilitation research center and entrepreneur.
[3:33] Discussion of the building of the rehabilitation institute in Toronto Health Network with a team of 90 people and the importance of working directly with patients.
[4:58] Popovic describes the translation of technology from lab to the marketplace particularly in functional electrical stimulation and human clinical trials to a start-up company.
[6:24] Steven Plymale describes how he was introduced to MyndTec and his initiation into a small, struggling start-up company. Hear how he was convinced that electrical stimulation is not voodoo science
[7:50] Plymale and Popovic describe the MyndMove device.. Discussion ensues about the impact on upper extremity rehabilitation and the involvement of the brain, the melody of the neural activity, and how this therapy capitalizes on the neuroplasticity in the brain.
[12:02] Plymale discusses the current stage of MyndMove in the project development spectrum including regulatory approvals, raising capital investment, and pricing model.
[15:26] What is the target market for the MyndTec neural re-education device? Plymale also talks about their pursuit for clinical partners, their strategic focus and the economics of the medical device as an early stage venture.
[18:06] Steven Plymale talks about his career journey in the medical device industry and how he enjoys start-up ventures.
[19:25] Popovic concludes talking about what excites him at RehabWeek and the potential relationships building from this meeting.